Presentation is loading. Please wait.

Presentation is loading. Please wait.

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc.

Published byImogene Burns Modified over 6 years ago

Similar presentations

Presentation on theme: "First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc."— Presentation transcript:

1 First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc Bosiers, MD, Thomas Zeller, MD, Martin Schillinger, MD, Els Boone, MSc, Margo J. Zaugg, BSN, Patrick Verta, MD, Lei Peng, MSc, Xingyu Gao, MSc, Lewis B. Schwartz, MD  Journal of Vascular Surgery  Volume 54, Issue 2, Pages (August 2011) DOI: /j.jvs Copyright © 2011 Society for Vascular Surgery Terms and Conditions

2 Fig 1 The Dynalink-E self-expanding everolimus-eluting stent.
Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Clinical results of the Superficial Femoral Artery Treatment with Drug-Eluting Stents (STRIDES) trial as assessed by Rutherford-Becker clinical category (RB). The number of patients evaluated at each interval is shown in parentheses. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Improvement in ambulation following endovascular intervention in the Superficial Femoral Artery Treatment with Drug-Eluting Stents (STRIDES) trial. Patients' ability to ambulate was measured at prespecified time intervals by the Walking Improvement Questionnaire (WIQ). The figure shows, at each interval of study, the percentage of patients that were able to ambulate the stated distances. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

5 Fig 4 Freedom from target lesion revascularization (solid line) and primary patency (dashed line) in the Superficial Femoral Artery Treatment with Drug-Eluting Stents (STRIDES) trial. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Download ppt "First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc."

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results  M. Ferreira, L. Lanziotti, M. Monteiro, G.

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results  M. Ferreira, L. Lanziotti, M. Monteiro, G.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication  Saskia.

Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication  Saskia.
Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease  Marc Husmann, MD,

Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease  Marc Husmann, MD,
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease  Andrew J. Meltzer, MD, Gautam.

Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease  Andrew J. Meltzer, MD, Gautam.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Endovascular treatment of internal iliac artery obstructive disease

Endovascular treatment of internal iliac artery obstructive disease
Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.
Validation of a new simple questionnaire to “estimate ambulation capacity by history” (EACH) in patients with claudication  Nafi Ouedraogo, MD, Guillaume.

Validation of a new simple questionnaire to “estimate ambulation capacity by history” (EACH) in patients with claudication  Nafi Ouedraogo, MD, Guillaume.
Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease  Gustavo S. Oderich, MD, Luke.

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease  Gustavo S. Oderich, MD, Luke.
Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L

Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease 

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease 
Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,
Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P

Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P
Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 

Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 

Similar presentations

Ads by Google